Frequency-dependent effects of diltiazem on the atrioventricular node during experimental atrial fibrillation.
- 1 August 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (2) , 380-389
- https://doi.org/10.1161/01.cir.80.2.380
Abstract
Calcium channel blockers depress atrioventricular (AV) nodal properties in vivo in a frequency-dependent manner, suggesting that selective drug action during supraventricular arrhythmias may result from use-dependent properties. The present study was designed to examine whether or not the rate-dependent actions of diltiazem account for its therapeutic effects during atrial fibrillation. The determinants of the ventricular response to atrial fibrillation (concealed AV nodal conduction and AV node functional refractory period, AVFRP) were evaluated at multiple cycle lengths (with extrastimulus techniques) and during electrically induced atrial fibrillation (with indirect indexes from RR interval histograms) in anesthetized dogs. In the presence of diltiazem, AVFRP increased progressively relative to control as rate accelerated. At cycle lengths comparable to sinus rhythm in humans, AVFRP increased 10%, 17%, and 32% after doses 1, 2, and 3 of diltiazem, respectively. Drug-induced increases in AVFRP were greater at basic cycle lengths just above the Wenckebach point (17%, 48%, and 81%) and were maximal during atrial fibrillation (39%, 86%, and 154% increases for doses 1, 2, and 3, respectively). Diltiazem also increased the AV conduction system effective refractory period, thereby increasing the potential zone of concealment into the AV node. Frequency-dependent increases in the zone of concealment were produced by diltiazem and were associated with marked increases in the standard deviation of RR interval histograms during atrial fibrillation (257%, 526%, and 923% increases after doses 1, 2, and 3, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 38 references indexed in Scilit:
- Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillationThe American Journal of Cardiology, 1988
- Effect of the calcium antagonist diltiazem on atrioventricular conduction in chronic atrial fibrillationThe American Journal of Cardiology, 1985
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Considerations on the nature of irregularity of the sequence of RR intervals and the function of the atrioventricular node in atrial fibrillation in man based on time series analysis.Japanese Heart Journal, 1984
- Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cellsNature, 1983
- Verapamil and digoxin: Their respective effects on atrial fibrillation and their interactionThe American Journal of Cardiology, 1982
- The Influence of Cycle Length On the Effective and Functional Refractory Period of the Human Av NodeAngiology, 1976
- A statistical study of the ventricular irregularity of atrial fibrillationComputers and Biomedical Research, 1967
- An experimental study of concealed conductionAmerican Heart Journal, 1964
- What is the reason for the ventricular arrhythmia in cases of auricular fibrillation?American Heart Journal, 1950